McKesson

Press enter to search
Close search
Open Menu

McKesson

McKesson promotes 2 execs amid community pharmacy restructure

Two McKesson pharmacy executives have new roles under a recent realignment of how the company approaches its community pharmacy customers. 

Vials of injectables.

Health officials prepare to distribute COVID-19 vaccine within 24 hours of FDA nod

The administration plans to use McKesson as its main distributor for a COVID-19 vaccine, which will be transported to distribution sites within 24 hours after the FDA grants an EU or approval.

More than 4,000 community pharmacies are immunizing this year.

A pharmacist with a mask spraying sanitizer on patient.

In a DSN webinar, Nancy Lyons, chief pharmacist at Health Mart and vice president of pharmaceutical solutions and services at McKesson, highlighted how independent pharmacies are rising to the challenge amid COVID-19.

Chris Dimos, who has been in the industry since he started as a pharmacist in 1989, will retire from McKesson in September.

McKesson headquarters.

McKesson's new four-segment structure includes two new reportable segments — prescription technology solutions and international.

A puzzle piece featuring a person.

Bansi Nagji, previously McKesson's executive vice president and chief strategy and business development officer, will serve as GoodRx's president of health care.

A puzzle piece featuring a person.

Tom Rodgers is McKesson's new executive vice president and chief strategy and business development officer, succeeding Bansi Nagji, who stepped down March 31.

McKesson headquarters.

McKesson’s pharmaceutical and specialty solutions segment saw revenue increase 13% over Q4 2019, totaling $46.3 billion, and full-year revenue for the segment rose 9% over the prior fiscal year, totaling $183.3 billion.

Health Mart is working with eTrueNorth to begin providing drive-through COVID-19 testing at certain Health Mart pharmacies.

A conference full of peoples sitting in front of a speaker.

McKesson has cancelled ideaShare 2020; looks forward to ideaShare 2021.

A puzzle piece with a stick figure.

McKesson is conducting a search for Bansi Nagji's successor, who is stepping down as executive vice president and chief strategy and business development officer, on March 31.

McKesson's pharmaceutical and specialty solutions segment saw Q3 2020 revenue up 6% over Q3 2019, totaling $46.9 billion.

A person signing a document and another hand holding a paper.

McKesson will continue its long-standing relationship with the VA Healthcare System under a new agreement that takes effect in August 2020.

Show More